Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Bryant

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Pharmacotherapy|July 1, 1986
Neuroleptic-induced catatonia after abrupt withdrawal of amantadine during neuroleptic therapyC S Brown, A K Wittkowsky, S G Bryant
Texas Medicine|August 1, 1978
Treatment of status epilepticus: a reviewS G Bryant, J P Allen, T M Ludden
Psychopharmacology Bulletin|January 1, 1987
A patient-initiated postmarketing surveillance systemS Fisher, S G Bryant, B L Solovitz, et al.
Texas Medicine|August 1, 1987
Statewide test of a new postmarketing drug surveillance systemS Fisher, S G Bryant, B L Solovitz, et al.
Journal of Clinical Pharmacology|November 1, 1987
Patient-initiated postmarketing surveillance: a validation studyS Fisher, S G Bryant, B L Solovitz, et al.
Pharmacotherapy|March 1, 1994
Patient drug attributions and postmarketing surveillanceS Fisher, S G Bryant, T A Kent, et al.
The Bulletin of the American Academy of Psychiatry and the Law|January 1, 1991
The diagnosis of intermittent explosive disorder in violent menA R Felthous, S G Bryant, C B Wingerter, et al.
Psychopharmacology Bulletin|January 1, 1987
How well can patients discriminate drug-related side effects from extraneous new symptoms?B L Solovitz, S Fisher, S G Bryant, et al.
The Journal of Clinical Psychiatry|February 1, 1984
Predicting lithium doseS G Bryant, B G Guernsey, J A Hokanson, et al.
American Journal of Hospital Pharmacy|June 1, 1985
Pharmacists' perceptions of mental health care, psychiatrists, and mentally ill patientsS G Bryant, B G Guernsey, E L Pearce, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Pharmacotherapy|July 1, 1986
Neuroleptic-induced catatonia after abrupt withdrawal of amantadine during neuroleptic therapyC S Brown, A K Wittkowsky, S G Bryant
Texas Medicine|August 1, 1978
Treatment of status epilepticus: a reviewS G Bryant, J P Allen, T M Ludden
Psychopharmacology Bulletin|January 1, 1987
A patient-initiated postmarketing surveillance systemS Fisher, S G Bryant, B L Solovitz, et al.
Texas Medicine|August 1, 1987
Statewide test of a new postmarketing drug surveillance systemS Fisher, S G Bryant, B L Solovitz, et al.
Journal of Clinical Pharmacology|November 1, 1987
Patient-initiated postmarketing surveillance: a validation studyS Fisher, S G Bryant, B L Solovitz, et al.
Pharmacotherapy|March 1, 1994
Patient drug attributions and postmarketing surveillanceS Fisher, S G Bryant, T A Kent, et al.
The Bulletin of the American Academy of Psychiatry and the Law|January 1, 1991
The diagnosis of intermittent explosive disorder in violent menA R Felthous, S G Bryant, C B Wingerter, et al.
Psychopharmacology Bulletin|January 1, 1987
How well can patients discriminate drug-related side effects from extraneous new symptoms?B L Solovitz, S Fisher, S G Bryant, et al.
The Journal of Clinical Psychiatry|February 1, 1984
Predicting lithium doseS G Bryant, B G Guernsey, J A Hokanson, et al.
American Journal of Hospital Pharmacy|June 1, 1985
Pharmacists' perceptions of mental health care, psychiatrists, and mentally ill patientsS G Bryant, B G Guernsey, E L Pearce, et al.
Pageof 5